Gara Jalqabaatti › Kansarii Pancreas › North Carolina › Durham
Qorannoo klinikaalii Kansarii Pancreas Durham, NC keessatti
Qorannoo 24 Kansarii Pancreas f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
A Study of PHN-012 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- PHN-012-001 Site, Durham
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
Namoota walitti qabaa jiraSadarkaa 3
- Duke Cancer Center, Durham
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
- Research Site, Durham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Namoota walitti qabaa jiraSadarkaa 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
- University of North Carolina Hospitals at Hillsborough, Hillsborough · Miili 13 fagaatti
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Namoota walitti qabaa jiraSadarkaa 3
- Duke Cancer Center, Durham
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 3
- Investigative Site US035, Chapel Hill · Miili 10 fagaatti
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Namoota walitti qabaa jiraSadarkaa 2
- Local Institution - 0100, Durham
Promoting CT Engagement for Pancreatic Cancer With App
Namoota walitti qabaa jira
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Namoota walitti qabaa jiraQorannoo ilaalaa
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
- University of North Carolina-Hillsborough Campus, Hillsborough · Miili 13 fagaatti
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Namoota walitti qabaa jiraSadarkaa 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · Miili 10 fagaatti
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Namoota walitti qabaa jiraSadarkaa 2
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Institute /ID# 276267, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Durham
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Namoota walitti qabaa jiraSadarkaa 1
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Duke Cancer Center, Durham
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
Namoota walitti qabaa jiraSadarkaa 1/2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
Qorannoo Kansarii Pancreas magaalota biroo keessatti
- Houston, TXQorannoo 61
- New York City, NYQorannoo 60
- Boston, MAQorannoo 43
- Nashville, TNQorannoo 39
- Los Angeles, CAQorannoo 35
- St. Louis, MOQorannoo 33
- Arlington, VAQorannoo 33
- Baltimore, MDQorannoo 31
- San Antonio, TXQorannoo 31
- Philadelphia, PAQorannoo 26
- Tampa, FLQorannoo 26
- San Diego, CAQorannoo 24
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 64
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 33
- Kansara MetastatikiiQorannoo 33
- Kansarii ProstateQorannoo 32
- Dhibee QaraQorannoo 32
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.